Outpace Bio

Developer of T-cell therapies for cancer treatment

placeSeattle, Washington, United States calendar_todayFounded 2020 groups48 employees language outpacebio.com

Registered entities

Innovation

16 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 357 times.

YearFilings
20212
20225
20238
20245
20258
20263

Social engagement

Social engagement: 7.2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Artis Ventures, Lyell Immunopharma, RA Capital Management.

Investor typeCountShare
Venture capital953%
Private equity212%
Other / undisclosed635%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

22 Oct 2025 · Senior Research Associate/Scientist I · Seattle

Based on job postings tracked across public sources.

Recent activity

9 Jan 2026
Event
JPM26
6 Oct 2025
Event
ARM's Meeting on the Mesa
14 Jul 2025
Event
Innovation Beyond Boundaries
Coming soon